ASCO GU 2020 Prostate Cancer - Results from #80

Viewing 81-92 of 92 articles

ASCO GU 2020: Individualizing Treatment in Localized Prostate Cancer

ASCO GU 2020: Changing Outcomes That Matter in Metastasis-Directed Therapy

ASCO GU 2020: Five-Year Results of a Randomized Phase II Trial, Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence (STOMP)

ASCO GU 2020: A Prospective Phase II/III Multicenter Study of PSMA - Targeted 18F - DCFPyL PET/CT Imaging in Patients with Prostate Cancer (OSPREY)

ASCO GU 2020: Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence (STOMP): Five-Year Results of a Randomized Phase II Trial

ASCO GU 2020: Optimal Integration of Systemic and Localized Treatment for High-Risk Localized Prostate Cancer: Radiation Oncologist

ASCO GU 2020: PSMA PET Who Should Undergo Advanced Imaging in the Current Era

ASCO GU 2020: Prostate-Specific Membrane Antigen PET: Who Should Undergo Advanced Imaging in the Current Era?

ASCO GU 2020: PSMA-targeted 18F-DCFPyL PET/CT Imaging in Patients with Prostate Cancer (OSPREY)

ASCO GU 2020: Multiparametric MRI in the Management of Localized Prostate Cancer

ASCO GU 2020: (OSPREY): A Sub-Analysis of Regional and Distant Metastases Detection Rates at Initial Staging

ASCO GU 2020: Optimal Use of Multiparametric MRI in the Management of Localized Prostate Cancer

1
2
3
4
5